Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calumenin (CALU) is a secreted, multifunctional calcium-binding protein with six EF-hand domains, predominantly localized in the endoplasmic reticulum and sarcoplasmic reticulum of mammalian cells. It plays critical roles in protein folding, sorting, and handling Ca²⁺ within cells. CALU also influences the activity of vitamin K-dependent proteins, cardiac Ca²⁺ cycling, cell migration, tumor progression, immune responses, and coagulation. Genetic variants in CALU are associated with variation in warfarin dose requirements and its expression may serve as a biomarker in certain cardiovascular and cancer settings. Its widespread physiological functions make it a possible therapeutic target, though interventions must consider the risk of broad systemic effects.
Modulation of vitamin K–dependent carboxylation (alters γ-carboxylase activity); Influences ERK1/2 signaling pathways in cancer, stabilizes matrix components (e.g., fibulin-1); Interaction with SERCA2 modulates intracellular calcium cycling; Interacts with thrombospondin-1 in platelets, affecting hemostasis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calumenin (CALU).